138 related articles for article (PubMed ID: 27572291)
1. Enhanced expression of semaphorin 3E is involved in the gastric cancer development.
Maejima R; Tamai K; Shiroki T; Yokoyama M; Shibuya R; Nakamura M; Yamaguchi K; Abue M; Oikawa T; Noguchi T; Miura K; Fujiya T; Sato I; Iijima K; Shimosegawa T; Tanaka N; Satoh K
Int J Oncol; 2016 Sep; 49(3):887-94. PubMed ID: 27572291
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression.
Roodink I; Kats G; van Kempen L; Grunberg M; Maass C; Verrijp K; Raats J; Leenders W
Am J Pathol; 2008 Dec; 173(6):1873-81. PubMed ID: 18974298
[TBL] [Abstract][Full Text] [Related]
3. Epigenetically downregulated Semaphorin 3E contributes to gastric cancer.
Chen H; Xie GH; Wang WW; Yuan XL; Xing WM; Liu HJ; Chen J; Dou M; Shen LS
Oncotarget; 2015 Aug; 6(24):20449-65. PubMed ID: 26036259
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways.
Aghajanian H; Choi C; Ho VC; Gupta M; Singh MK; Epstein JA
J Biol Chem; 2014 Jun; 289(26):17971-9. PubMed ID: 24825896
[TBL] [Abstract][Full Text] [Related]
5. Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.
Casazza A; Kigel B; Maione F; Capparuccia L; Kessler O; Giraudo E; Mazzone M; Neufeld G; Tamagnone L
EMBO Mol Med; 2012 Mar; 4(3):234-50. PubMed ID: 22247010
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis.
Moriya J; Minamino T; Tateno K; Okada S; Uemura A; Shimizu I; Yokoyama M; Nojima A; Okada M; Koga H; Komuro I
Circ Res; 2010 Feb; 106(2):391-8. PubMed ID: 19940264
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism.
Kim J; Oh WJ; Gaiano N; Yoshida Y; Gu C
Genes Dev; 2011 Jul; 25(13):1399-411. PubMed ID: 21724832
[TBL] [Abstract][Full Text] [Related]
8. Vascular Sema3E-Plexin-D1 Signaling Reactivation Promotes Post-stroke Recovery through VEGF Downregulation in Mice.
Yu R; Kim NS; Li Y; Jeong JY; Park SJ; Zhou B; Oh WJ
Transl Stroke Res; 2022 Feb; 13(1):142-159. PubMed ID: 33978913
[TBL] [Abstract][Full Text] [Related]
9. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.
Casazza A; Finisguerra V; Capparuccia L; Camperi A; Swiercz JM; Rizzolio S; Rolny C; Christensen C; Bertotti A; Sarotto I; Risio M; Trusolino L; Weitz J; Schneider M; Mazzone M; Comoglio PM; Tamagnone L
J Clin Invest; 2010 Aug; 120(8):2684-98. PubMed ID: 20664171
[TBL] [Abstract][Full Text] [Related]
10. MiR-4282 suppresses proliferation and mobility of human colorectal carcinoma cells by targeting semaphorin 3E.
Kang X; Wang M; Wang H; Shen X; Guan W
Panminerva Med; 2016 Sep; 58(3):197-205. PubMed ID: 27120047
[TBL] [Abstract][Full Text] [Related]
11. Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue.
Al-Shareef H; Hiraoka SI; Tanaka N; Shogen Y; Lee AD; Bakhshishayan S; Kogo M
Oncol Rep; 2016 Nov; 36(5):2444-2454. PubMed ID: 27666723
[TBL] [Abstract][Full Text] [Related]
12. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
[TBL] [Abstract][Full Text] [Related]
13. Binding and complementary expression patterns of semaphorin 3E and plexin D1 in the mature neocortices of mice and monkeys.
Watakabe A; Ohsawa S; Hashikawa T; Yamamori T
J Comp Neurol; 2006 Nov; 499(2):258-73. PubMed ID: 16977617
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.
Sakurai A; Jian X; Lee CJ; Manavski Y; Chavakis E; Donaldson J; Randazzo PA; Gutkind JS
J Biol Chem; 2011 Sep; 286(39):34335-45. PubMed ID: 21795701
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome.
Cariboni A; André V; Chauvet S; Cassatella D; Davidson K; Caramello A; Fantin A; Bouloux P; Mann F; Ruhrberg C
J Clin Invest; 2015 Jun; 125(6):2413-28. PubMed ID: 25985275
[TBL] [Abstract][Full Text] [Related]
16. Neuronal chemorepellent Semaphorin 3E inhibits human airway smooth muscle cell proliferation and migration.
Movassagh H; Shan L; Halayko AJ; Roth M; Tamm M; Chakir J; Gounni AS
J Allergy Clin Immunol; 2014 Feb; 133(2):560-7. PubMed ID: 23932461
[TBL] [Abstract][Full Text] [Related]
17. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.
Kigel B; Varshavsky A; Kessler O; Neufeld G
PLoS One; 2008 Sep; 3(9):e3287. PubMed ID: 18818766
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival.
Yong LK; Lai S; Liang Z; Poteet E; Chen F; van Buren G; Fisher W; Mo Q; Chen C; Yao Q
Oncotarget; 2016 Dec; 7(52):87431-87448. PubMed ID: 27911862
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis.
Christensen C; Ambartsumian N; Gilestro G; Thomsen B; Comoglio P; Tamagnone L; Guldberg P; Lukanidin E
Cancer Res; 2005 Jul; 65(14):6167-77. PubMed ID: 16024618
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
